IDB-9170 · Biotech
Biomanufacturing MES for Cell and Gene Therapy CDMOs
B2BenterpriseSaaS
Opportunity score
83/100
graded across 14 signals
Momentum (90d)
↑ +26%
trailing 90 days
Market size (TAM)
$4.9B
primary US + global
Competition
MEDIUM
incumbents tracked
Difficulty
HARD
technical + GTM
Time to market
7mo
to first revenue
Revenue model
SaaS
primary monetization
Search trend · trailing 24 weeks
Loading deep-dive…